Pearl River's Acorda Therapeutics ceases operations, 97 jobs affected
Operations at Acorda are slated to wind down completely by June 1
News 12 Staff
•
Apr 8, 2024, 4:36 PM
•
Updated 40 days ago
Share:
More Stories
1:41
Croton to flip commuter lot into new housing
3ds ago4:17
be Well: What you need to know when deciding to make a will
3ds ago0:18
Aldi recalls 4 types of cream cheese over potential salmonella risk
3ds ago3:00
be Well: Fire safety for seniors
4ds ago0:36
Hudson Valley Red Lobster locations abruptly close, workers say staff turned away without notice
4ds ago0:28
Film Preservation Festival in full swing at Jacob Burns Film Center
4ds ago1:41
Croton to flip commuter lot into new housing
3ds ago4:17
be Well: What you need to know when deciding to make a will
3ds ago0:18
Aldi recalls 4 types of cream cheese over potential salmonella risk
3ds ago3:00
be Well: Fire safety for seniors
4ds ago0:36
Hudson Valley Red Lobster locations abruptly close, workers say staff turned away without notice
4ds ago0:28
Film Preservation Festival in full swing at Jacob Burns Film Center
4ds agoPearl River's Acorda Therapeutics, a developer of therapies for neurological disorders such as Parkinson's disease, has announced its closure.
This decision will directly impact 97 employees, according to statements released by the company.
The company, known for its commitment to advancing treatments for challenging conditions, has filed for Chapter 11 bankruptcy. The closure comes despite recent negotiations for acquisition by Merz Therapeutics, signaling a shift in the company's trajectory.
Operations at Acorda are slated to wind down completely by June 15.
